191 related articles for article (PubMed ID: 36522191)
21. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
Cheson BD; Fisher RI; Barrington SF; Cavalli F; Schwartz LH; Zucca E; Lister TA; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
J Clin Oncol; 2014 Sep; 32(27):3059-68. PubMed ID: 25113753
[TBL] [Abstract][Full Text] [Related]
22.
Albano D; Treglia G; Gazzilli M; Cerudelli E; Giubbini R; Bertagna F
Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):422-430. PubMed ID: 32169480
[TBL] [Abstract][Full Text] [Related]
23. FDG-PET/CT in the management of lymphomas: current status and future directions.
El-Galaly TC; Villa D; Gormsen LC; Baech J; Lo A; Cheah CY
J Intern Med; 2018 Oct; 284(4):358-376. PubMed ID: 29989234
[TBL] [Abstract][Full Text] [Related]
24. Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma.
Kim YR; Kim SJ; Cheong JW; Kim Y; Jang JE; Cho H; Chung H; Min YH; Yang WI; Cho A; Kim JS
Korean J Intern Med; 2021 Mar; 36(Suppl 1):S245-S252. PubMed ID: 32550718
[TBL] [Abstract][Full Text] [Related]
25. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
[TBL] [Abstract][Full Text] [Related]
26. Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas.
Karam M; Novak L; Cyriac J; Ali A; Nazeer T; Nugent F
Cancer; 2006 Jul; 107(1):175-83. PubMed ID: 16721817
[TBL] [Abstract][Full Text] [Related]
27. F-18 FDG PET for evaluation of bone marrow involvement in non-Hodgkin lymphoma: a meta-analysis.
Chen YK; Yeh CL; Tsui CC; Liang JA; Chen JH; Kao CH
Clin Nucl Med; 2011 Jul; 36(7):553-9. PubMed ID: 21637057
[TBL] [Abstract][Full Text] [Related]
28. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.
Weiler-Sagie M; Bushelev O; Epelbaum R; Dann EJ; Haim N; Avivi I; Ben-Barak A; Ben-Arie Y; Bar-Shalom R; Israel O
J Nucl Med; 2010 Jan; 51(1):25-30. PubMed ID: 20009002
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma.
Ulaner GA; Goldman DA; Sauter CS; Migliacci J; Lilienstein J; Gönen M; Schöder H; Moskowitz CH; Zelenetz AD
Radiology; 2015 Nov; 277(2):518-26. PubMed ID: 26035588
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M
Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320
[TBL] [Abstract][Full Text] [Related]
31. Current Role of Functional Imaging in the Management of Lymphoma.
Cheson BD; Meignan M
Curr Oncol Rep; 2021 Nov; 23(12):144. PubMed ID: 34735647
[TBL] [Abstract][Full Text] [Related]
32. Imaging of non-Hodgkin lymphomas: diagnosis and response-adapted strategies.
El-Galaly TC; Hutchings M
Cancer Treat Res; 2015; 165():125-46. PubMed ID: 25655608
[TBL] [Abstract][Full Text] [Related]
33. The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma.
Qiu L; Tu G; Li J; Chen Y
Nucl Med Commun; 2017 Feb; 38(2):106-116. PubMed ID: 27792043
[TBL] [Abstract][Full Text] [Related]
34. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of 18F-FDG PET/CT for evaluating response of ocular adnexal lymphoma to treatment.
Fujii H; Tanaka H; Nomoto Y; Harata N; Oota S; Isogai J; Yoshida K
Medicine (Baltimore); 2018 Apr; 97(17):e0543. PubMed ID: 29703034
[TBL] [Abstract][Full Text] [Related]
36. Quarter-Century PET/CT Transformation of Oncology: Lymphoma.
Parihar AS; Pant N; Subramaniam RM
PET Clin; 2024 Apr; 19(2):281-290. PubMed ID: 38403384
[TBL] [Abstract][Full Text] [Related]
37. [The role of PET/CT investigation in the management of patients with diffuse large B-cell lymphoma].
Paksi M; Demeter J; Szabó P
Magy Onkol; 2016 Jun; 60(2):108-17. PubMed ID: 27275637
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
39. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.
Pelosi E; Pregno P; Penna D; Deandreis D; Chiappella A; Limerutti G; Vitolo U; Mancini M; Bisi G; Gallo E
Radiol Med; 2008 Jun; 113(4):578-90. PubMed ID: 18414808
[TBL] [Abstract][Full Text] [Related]
40. Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma.
Blum RH; Seymour JF; Wirth A; MacManus M; Hicks RJ
Clin Lymphoma; 2003 Jun; 4(1):43-9. PubMed ID: 12837154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]